To verify our hypothesis, we investigated the change of cellular ROS level upon MARS2 knockdown using anti-MARS2 siRNA in A549 non-small-cell lung cancer (NSCLC) cells (Fig. 1a). Here, MARS2 is linked to non-small cell lung carcinoma.